Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
BACK TO LIST

European Patient Summary

Patient
Name: Frydrychowicz, , Andrzej,
DOB: 12-APR-1974 (Age: 51)
Gender: male
ID: 7036-931598-4 (ECI)
Author
Dr. Ping, Hel
Patient summary Document
European Patient Summary
Report Date: 17-AUG-2024

Problem list

Condition Onset Date Status
Ischemic heart disease 06-Aug-2022 active
Osteoarthritis of knee 24-Oct-2021 active
Prediabetes 20-Aug-2005 active
Anemia 20-Aug-2005 active

Medication list

Medication Since Form Dosage Reason
Acetaminophen 325 mg oral tablet 2024-08-17 - 1 tablet (325 mg) by mouth every 4 to 6 hours as needed -
Clopidogrel (as clopidogrel bisulfate) 75 mg oral tablet 2022-08-13 - 1 tablet (75 mg) once daily -
Simvastatin 20 mg oral tablet 2022-08-13 - 1 tablet (20 mg) by mouth once daily -
Nitroglycerin 400 microgram/actuation sublingual spray 2022-08-13 - 400 micrograms (1 spray) under the tongue as needed for chest pain, repeat every 5 minutes if needed, up to 3 sprays in 15 minutes -
Metoprolol tartrate (as metoprolol succinate) 100 mg prolonged-release oral tablet 2022-08-13 - 1 tablet (100 mg) once daily -
Naproxen sodium 220 mg oral capsule 2021-10-24 - 1 tablet (220 mg) by mouth every 12 hours as needed Osteoarthritis of knee

Immunizations list

Vaccine Date
Influenza virus antigen only vaccine product 17-Aug-2024
Clostridium tetani toxoid antigen adsorbed only vaccine product 06-Aug-2022
Live attenuated Human alphaherpesvirus 3 only vaccine product 06-Aug-2022
SARS-CoV-2 mRNA vaccine 10-Apr-2021

Procedure History list

Procedure Date Reason
Medication reconciliation 16-Mar-2019 -
Assessment of health and social care needs 16-Mar-2019 -

Allergies and Intolerances

Allergy/Intolerance Onset Date Status Type Reaction
? active ?

Care Plan

Active Planned Care / Goals Start Date Reason
Musculoskeletal care 24-Oct-2021 Osteoarthritis of knee
  • Reduce knee pain severity to a tolerable level to improve function and quality of life.
  • Increase ability to walk and perform daily activities without significant limitation from knee osteoarthritis.
  • Decrease swelling and inflammation in the affected knee to improve comfort and mobility.
Diabetes self management plan 20-Aug-2005 Prediabetes
  • Achieve and maintain HbA1c below 6.5% through lifestyle modification and self-management.
  • Reduce body weight to support improved glucose metabolism.
  • Engage in at least 150 minutes of moderate-intensity physical activity per week.
  • Maintain blood pressure below 130/80 mmHg to reduce cardiovascular risk.

Vital Signs

Vital Signs 2024-08-17 2023-08-12
Body Height 190.2 cm 190.2 cm
Pain severity - 0-10 verbal numeric rating [Score] - Reported 4 {score} 4 {score}
Body Weight 109.7 kg 109.7 kg
Body mass index (BMI) [Ratio] 30.3 kg/m2 30.3 kg/m2
Diastolic Blood Pressure 51 mm[Hg] 44 mm[Hg]
Systolic Blood Pressure 95 mm[Hg] 85 mm[Hg]
Heart rate 75 /min 96 /min
Respiratory rate 15 /min 16 /min

Relevant diagnostic tests/laboratory data

Recent Lab Observations 17-AUG-2024 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 5.9 4.3 - 6.4 %
Glucose [Mass/volume] in Blood 90.3 70 - 140 mg/dL
Urea nitrogen [Mass/volume] in Blood 7.2 7 - 20 mg/dL
Creatinine [Mass/volume] in Blood 1.4 H 0.6 - 1.3 mg/dL
Calcium [Mass/volume] in Blood 9.0 8.5 - 10.5 mg/dL
Sodium [Moles/volume] in Blood 136.6 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 5.1 3.5 - 5.3 mmol/L
Chloride [Moles/volume] in Blood 110.0 98 - 110 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 28.8 22 - 29 mmol/L

Device Use

Device Date (since)
Wheelchair accessory (physical object) 24-Oct-2021
Power-assisted wheelchair (physical object) 24-Oct-2021
Blood glucose meter (physical object) 20-Aug-2005